N/A N=20 Comparison of Tissue Oxygenation Measurement Using Multimodal Devices
Oxygen Saturation
Primary: Device-wise Comparison of Tissue Oxygenation Measurement — 62.7; 91.2; 97.58; 97.95 percentage of oxygen
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=800 VITAL Start: Brief Facility-based Video Intervention
HIV/AIDS
Primary: Composite of Retention in ART Clinic and Viral Suppression — 206; 220 Participants — p=0.49
N/A N=1,052 Effect of Presenting Survival Information as Text or Pictograph During Periviable Birth Counseling
Premature Birth
Primary: Hypothetical Treatment Choice — 130; 135; 143; 126 Participants
Phase 3 N=4,570 Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
HIV Infections
Primary: Number of Participants With Documented Incident HIV Infections During Steps 1 and 2 — 13; 39 Participants — p=0.0005
N/A N=2,097 COVID-19 Watch + COVID-19 Pulse
Covid19
Primary: Difference in Days Alive and Out of Hospital — 29.5; 29.4 days
N/A N=40 Citicoline in Non-Arteritic Ischemic Optic Neuropathy
Non-arteritic Ischemic Optic Neuropathy
Primary: Change From Baseline in Visual Acuity at 9 Month — -0.0574; 0.0535 LogMAR
Phase 2 N=19 Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase
Gastrointestinal Cancer · Biliary Tract Cancer
Primary: Part 1: Establish the Maximum Tolerated Dose (MTD) — 100 mg
N/A N=164 Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and Anastomosis
Gastrointestinal Neoplasm
Primary: Number of Participants With Anastomosis Success — 80; 80 Participants — p=<0.05
N/A N=30 Intrathoracic Esophagogastric Anastomosis After Robot Assisted Minimally Invasive Esophagectomy Using STRATAFIX
Esophageal Cancer
Primary: Anastomotic Leak Rate After Esophagectomy
N/A N=62 A Novel Strategy to Decrease Fall Incidence Post-Stroke
Stroke
Primary: Fall Incidence (Number of Falls) — 88; 56 number of falls
Phase 3 N=1,134 Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
SARS-CoV-2 Infection · COVID-19
Primary: Percentage of Participants With Local Reactions Within 7 Days After Vaccination 1 — 7.6; 0.5; 6.2; 0.5 Percentage of participants
Phase 1 N=8 A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.
Rare Diseases
Primary: The Maximum Observed Concentration of Emapalumab — 23980 ng/mL
Phase 3 N=77 Homeopathic Treatment of Post-acute COVID-19 Syndrome
Post-acute Covid-19 Syndrome
Primary: Fatigue Assessment Scale (FAS) — 32.9; 31.4; 29.0; 27.4 score on a scale
N/A N=100 Nutritional Impact of Moringa Oleifera Leaf Supplementation in Mothers and Children
Malnutrition · Wasting · Growth Failure
Primary: Change in Body Weight — 365; 2.5; -470; 2.5 g
N/A N=50 Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis
Vaginitis and Vulvovaginitis
Primary: Number of Participants With the Same Gynaecological Conditions at the End of Treatment Visit — 13 Participants